Free Trial

Blueprint Medicines (BPMC) SEC Filings & 10K Form

$102.18
-0.53 (-0.52%)
(As of 12:21 PM ET)

Recent Blueprint Medicines SEC Filings

DateFilerForm TypeView
05/06/2024
4:19 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:26 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:43 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
6:09 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
6:09 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
4:24 PM
Blueprint Medicines (Filer)
Form DEF 14A
04/25/2024
4:25 PM
Blueprint Medicines (Filer)
Form ARS
04/25/2024
7:30 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
11:58 AM
Blueprint Medicines (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
03/28/2024
4:57 PM
Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
8:11 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:50 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:22 PM
Blueprint Medicines (Subject)
Landsittel Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
3:46 PM
Blueprint Medicines (Subject)
Hurley Ariel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
3:47 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:17 PM
Blueprint Medicines (Subject)
Lee Philina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
5:24 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:26 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:27 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:28 PM
Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:29 PM
Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:15 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:18 PM
Blueprint Medicines (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:19 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:20 PM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:21 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:23 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:22 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:15 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:16 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:17 PM
Blueprint Medicines (Issuer)
Landsittel Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:18 PM
Blueprint Medicines (Issuer)
Haviland Kate (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:19 PM
Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
Blueprint Medicines (Issuer)
Rossi Christina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:20 PM
Blueprint Medicines (Issuer)
Durso-Bumpus Debra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:21 PM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
9:41 AM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:19 PM
Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
2:06 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
3:03 PM
Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
7:20 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Dividend-like income from non-dividend stocks (Ad)

This coming Wednesday @ 7 PM EST you're going to discover… How to find safe value in the stocks you already own with simple Cash Flow Trade Strategies.

Click here to register for free.
02/16/2024
3:40 PM
Blueprint Medicines (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/15/2024
4:26 PM
Blueprint Medicines (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
6:05 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
5:54 PM
Blueprint Medicines (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:35 AM
Blueprint Medicines (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/29/2024
5:13 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Blueprint Medicines (Subject)
Form SC 13G/A
01/10/2024
9:16 AM
Blueprint Medicines (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/08/2024
7:03 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
3:24 PM
Blueprint Medicines (Issuer)
Hurley Ariel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
2:56 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
5:09 PM
Blueprint Medicines (Subject)
Murray Christopher K. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
7:45 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
12:17 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
8:02 AM
Blueprint Medicines (Subject)
FMR LLC (Filed by)
Form SC 13G/A
10/30/2023
1:01 PM
Blueprint Medicines (Issuer)
Murray Christopher K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
6:00 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2023
9:47 AM
Blueprint Medicines (Issuer)
Namouni Fouad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
1:36 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
5:23 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
7:15 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2023
3:21 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/02/2023
3:02 PM
Blueprint Medicines (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2023
6:00 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
5:03 AM
Blueprint Medicines (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2023
6:00 PM
Beckman Daniella (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
6:02 PM
Blueprint Medicines (Issuer)
Lydon Nicholas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
6:03 PM
Blueprint Medicines (Issuer)
Borisy Alexis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
6:04 PM
Blueprint Medicines (Issuer)
COATS LONNEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
6:04 PM
Blueprint Medicines (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
6:05 PM
Blueprint Medicines (Issuer)
Tsai John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
6:06 PM
Blueprint Medicines (Issuer)
Seely Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
6:06 PM
Blueprint Medicines (Issuer)
Goldberg Mark Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
6:07 PM
Albers Jeffrey W. (Reporting)
Blueprint Medicines (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
6:52 PM
Blueprint Medicines (Issuer)
Carter Percy H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
6:48 PM
Blueprint Medicines (Issuer)
Hewes L. Becker (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BPMC) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners